Skip to main content

Advertisement

SpringerLink
Log in

Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Acute exacerbations of chronic hepatitis B are common, and may even be the first presentation of hepatitis B virus (HBV) infection. Sometimes, patients involved in these scenarios may have mistaken diagnosis of acute hepatitis B. The reason for the confusion is that the two forms of infection manifestation resemble remarkably in clinical, biochemical, and serological features, such as apparent rapid onset of severe disease, advanced grades of encephalopathy, high aminotransferases and prolonged international normalized ratios (INRs), as well as positivity for HBsAg and for IgM anti-HBc antibodies and DNA detection. Therefore, these two entities cannot be distinguished easily without historical information of HBV-associated chronic infection or recent HBV exposure, information that is often inaccurate. Considering the different prognoses, treatment strategies, and the epidemiological impact in the public health context, the correct diagnosis is extremely important. Despite the lack of effective and reliable tests to differentiate between acute infection and acute exacerbation of chronic HBV infection, the expression and kinetic evaluation of viral markers present in the circulation of individuals infected, the observation of physical-chemical properties of specific antibodies, and the combination of these findings represent some strategies in serology that could assist in differentiating between the two entities, or at least in the guidance for the correct diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hoofnagle JH (2009) Reactivation of hepatitis B. Hepatology 49:S156–S165

    Article  PubMed  CAS  Google Scholar 

  2. Jindal A, Kumar M, Sarin SK (2013) Management of acute hepatitis B and reactivation of hepatitis B. Liver Int 33(Suppl 1):164–175

    Article  PubMed  CAS  Google Scholar 

  3. Puri P (2013) Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol 3(4):301–312

    Article  PubMed  PubMed Central  Google Scholar 

  4. Oketani M, Uto H, Ido A, Tsubouchi H (2014) Management of hepatitis B virus-related acute liver failure. Clin J Gastroenterol 7(1):19–26

    Article  PubMed  Google Scholar 

  5. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46:2050–2068

    PubMed  CAS  Google Scholar 

  6. Gupta S, Govindarajan S, Fong TL, Redeker AG (1990) Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol 12:562–568

    Article  PubMed  CAS  Google Scholar 

  7. Kumar M, Jain S, Sharma BC, Sarin SK (2006) Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci 51(3):594–599

    Article  PubMed  Google Scholar 

  8. Alexopoulou A, Baltayiannis G, Eroglu C, Nastos T, Dourakis SP, Archimandritis AJ, Karayiannis P (2009) Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values. J Med Virol 81(1):34–41

    Article  PubMed  CAS  Google Scholar 

  9. Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234:1398–1401

    Article  PubMed  CAS  Google Scholar 

  10. Brunetto MR, Torrani Cerenzia M, Oliveri F, Piantino P, Randone A, Calvo PL, Manzini P, Rocca G, Galli C, Bonino F (1993) Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 19:431–436

    Article  PubMed  CAS  Google Scholar 

  11. Gerlich WH, Uy A, Lambrecht F, Thomssen R (1986) Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol 24:288–293

    PubMed  PubMed Central  CAS  Google Scholar 

  12. Lemon SM, Gates NL, Simms TE, Bancroft WH (1981) IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. J Infect Dis 143:803–809

    Article  PubMed  CAS  Google Scholar 

  13. Han Y, Tang Q, Zhu W, Zhang X, You L (2008) Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. J Gastroenterol Hepatol 23:1728–1733

    Article  PubMed  Google Scholar 

  14. Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N (2006) Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol 37:206–212

    Article  PubMed  CAS  Google Scholar 

  15. Dao DY, Hynan LS, Yuan H-J, Sanders C, Balko J, Attar N, Lok AS, Word RA, Lee WM; Acute Liver Failure Study Group (2012) Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels. Hepatology 55:676–684

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Park JW, Kwak KM, Kim SE, Jang MK, Kim DJ, Lee MS, Kim HS, Park CK (2015) Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. World J Gastroenterol 21(13):3953–3959

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Huang Y-W, Lin C-L, Chen P-J, Lai M-Y, Kao J-H, Chen D-S (2006) Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. J Gastroenterol Hepatol 21:859–862

    Article  PubMed  CAS  Google Scholar 

  18. Tassopoulos NC, Sjogren MH, Purcell RH (1990) 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage. Infection 18(6):376–380

    Article  PubMed  CAS  Google Scholar 

  19. Sjogren MH, Lemon SM (1983) Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus. J Infect Dis 148(3):445–451

    Article  PubMed  CAS  Google Scholar 

  20. Tsuda F, Naito S, Takai E, Akahane Y, Furuta S, Miyakawa Y, Mayumi M (1984) Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Gastroenterology 87(1):159–164

    PubMed  CAS  Google Scholar 

  21. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G (2002) Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 40:4015–4020

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Terkmani H, Visseaux B, Ratziu V, Poynard T, Thibault V (2005) Anti-HBc antibody avidity determination allows rapid discrimination between acute hepatitis B and hepatitis B reactivation. Hepatology 42:717A–718A

  23. Hazell SL (2007) Clinical utility of avidity assays. Expert Opin Med Diagn 1(4):511–519. doi:10.1517/17530059.1.4.511

    Article  PubMed  Google Scholar 

  24. Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kır M, Baksu A, Ozel E, Camlıbel T (2014) Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet 290(6):1115–1120

    Article  PubMed  CAS  Google Scholar 

  25. Levett PN, Sonnenberg K, Sidaway F, Shead S, Niedrig M, Steinhagen K, Horsman GB, Drebot MA (2005) Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol 43(12):5873–5875

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Gaudy-Graffin C, Lesage G, Kousignian I, Laperche S, Girault A, Dubois F, Goudeau A, Barin F (2010) Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection. J Clin Microbiol 48(9):3281–3287. doi:10.1128/JCM.00303-10

    Article  PubMed  PubMed Central  Google Scholar 

  27. Desbois D, Grangeot-Keros L, Roquebert B, Roque-Afonso AM, Mackiewicz V, Poveda JD, Dussaix E (2005) Usefulness of specific IgG avidity for diagnosis of hepatitis A infection. Gastroenterol Clin Biol 29(5):573–576

    Article  PubMed  CAS  Google Scholar 

  28. Chen YC, Jeng WJ, Chu CM, Liaw YF (2012) Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection. Clin Gastroenterol Hepatol 10:297–302

    Article  PubMed  CAS  Google Scholar 

  29. Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, Perelson AS (2001) Kinetics of acute hepatitis B virus infection in humans. J Exp Med 193:847–854

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Gerlich W, Stamm B, Thomssen R (1977) Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of “virus hepatitis”. Verh Dtsch Ges Inn Med 83:554–557

    PubMed  CAS  Google Scholar 

  31. Frösner GG, Schomerus H, Wiedmann KH, Zachoval R, Bayerl B, Bäcker U, Gathof GA, Sugg U (1982) Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. Eur J Clin Microbiol 1:52–58

    Article  PubMed  Google Scholar 

  32. Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH (2003) Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 69:313–323

    Article  PubMed  CAS  Google Scholar 

  33. Yotsuyanagi H, Ito K, Yamada N, Takahashi H, Okuse C, Yasuda K, Suzuki M, Moriya K, Mizokami M, Miyakawa Y, Koike K (2013) High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. Clin Infect Dis 57(7):935–942

    Article  PubMed  CAS  Google Scholar 

  34. Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL (2008) Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology 135:459–467

    Article  PubMed  CAS  Google Scholar 

  35. Chu C-M, Liaw YF (2010) Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther 15:133–143

    Article  PubMed  Google Scholar 

  36. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M (2010) Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52:514–522

    Article  PubMed  CAS  Google Scholar 

  37. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA (2010) Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 52:508–513

    Article  PubMed  CAS  Google Scholar 

  38. Lok ASF, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661–662

    Article  PubMed  Google Scholar 

  39. Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ (2010) A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 52:1232–1241

    Article  PubMed  CAS  Google Scholar 

  40. Gayno S, Marcellin P, Loriot MA, Martinot-Peignoux M, Levy P, Erlinger S, Benhamou JP (1992) Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B. J Hepatol 14:357–360

    Article  PubMed  CAS  Google Scholar 

  41. Pondé RA (2013) Atypical serological profiles in hepatitis B virus infection. Eur Clin Microbiol Infect Dis 32(4):461–476

    Article  CAS  Google Scholar 

  42. Lok AS, Lai C-L (1990) Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol 10:29–34

    Article  PubMed  CAS  Google Scholar 

  43. Maruyama T, Schödel F, Iino S, Koike K, Yasuda K, Peterson D, Milich DR (1994) Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 106:1006–1015

    PubMed  CAS  Google Scholar 

  44. Orenbuch-Harroch E, Levy L, Ben-Chetrit E (2008) Acute hepatitis B or exacerbation of chronic hepatitis B—that is the question. World J Gastroenterol 14(46):7133–7137

    Article  PubMed  PubMed Central  Google Scholar 

  45. Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM, Bertoletti A (2000) Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32:1117–1124

    Article  PubMed  CAS  Google Scholar 

  46. Pawlotsky J-M (2003) Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 39:S31–S35

    Article  PubMed  CAS  Google Scholar 

  47. Thibault V, Laperche S, Thiers V, Sayon S, Letort M-J, Delarocque-Astagneau E, Antona D (2013) Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system. PLoS One 8(9), e75267. doi:10.1371/journal.pone.0075267

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20:992–1000

    Article  PubMed  CAS  Google Scholar 

  49. Rehermann B (2003) Immune responses in hepatitis B virus infection. Semin Liver Dis 23(1):21–38

    Article  PubMed  CAS  Google Scholar 

  50. Kamitsukasa H, Iri M, Tanaka A, Nagashima S, Takahashi M, Nishizawa T, Okamoto H (2015) Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol 87(4):589–600

    Article  PubMed  CAS  Google Scholar 

  51. Kowazaki Y, Osawa Y, Imamura J, Ohashi K, Sakamaki H, Kimura K (2015) Immunological analysis of a patient with hepatitis B virus (HBV) reactivation after bone marrow transplantation. Intern Med 54:1213–1217

    Article  PubMed  Google Scholar 

  52. Yang Y, Du Y, Luo WX, Li C, Chen Y, Cheng K, Ding J, Zhou Y, Ge J, Yang X, Liu JY (2015) Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer Chemother Pharmacol 75(4):783–790

    Article  PubMed  CAS  Google Scholar 

  53. Moon WR, Moon DS, Kim J, Yoon YM, Choi BS, Chung CH, Park SG (2015) Reactivation of hepatitis B (reverse seroconversion) after melphalan/dexamethasone therapy for primary amyloidosis: a case report. J Med Case Rep 9:122. doi:10.1186/s13256-015-0610-z

    Article  PubMed  PubMed Central  Google Scholar 

  54. Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, Choi MS, Lee JH, Jung CW, Jang JH, Kim WS, Kim SJ, Kim K (2015) Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver Int 35:2363–2369. doi:10.1111/liv.12838

    Article  PubMed  CAS  Google Scholar 

  55. Altfeld M, Rockstroh JK, Addo M, Kupfer B, Pult I, Will H, Spengler U (1998) Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 29:306–309

    Article  PubMed  CAS  Google Scholar 

  56. Clark SJ, Creighton S, Horner M, Smith HM, Portmann B, Taylor C, Cramp ME (2006) Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression. Int J STD AIDS 17(1):67–69

    Article  PubMed  CAS  Google Scholar 

  57. Shouval D, Shibolet O (2013) Immunosuppression and HBV reactivation. Semin Liver Dis 33(2):167–177

    Article  PubMed  CAS  Google Scholar 

  58. Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46:160–170

    Article  PubMed  Google Scholar 

  59. Bertoletti A, Tan AT, Gehring AJ (2009) HBV-specific adaptive immunity. Viruses 1:91–103

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Chisari FV, Isogawa M, Wieland SF (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58(4):258–266

    Article  CAS  Google Scholar 

  61. Ohishi W, Chayama K (2011) Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy. Clin Exp Nephrol 15:634–640

    Article  PubMed  CAS  Google Scholar 

  62. Gerlich WH (2006) Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36(Suppl 1):S18–S22

    Article  PubMed  CAS  Google Scholar 

  63. Umemura T, Kiyosawa K (2006) Fatal HBV reactivation in a subject with anti-HBs and anti-HBc. Intern Med 45(12):747–748

    Article  PubMed  Google Scholar 

  64. Sera T, Hiasa Y, Michitaka K, Konishi I, Matsuura K, Tokumoto Y, Matsuura B, Kajiwara T, Masumoto T, Horiike N, Onji M (2006) Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 45(11):721–724

    Article  PubMed  Google Scholar 

  65. You CR, Jang JW, Choi JK, Bae SH, Yoon SK, Kay CS, Choi JY (2010) Hepatic failure caused by reactivation of YMDD mutants occurring during preemptive lamivudine therapy. Gut Liver 4(2):262–265

    Article  PubMed  PubMed Central  Google Scholar 

  66. Pan HY, Pan HY, Chen L, Yang DH, Huang HJ, Tong YX, Chen CR, Yan J (2015) Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients. Clin Microbiol Infect. doi:10.1016/j.cmi.2015.07.023

  67. Seetharam A, Perrillo R, Gish R (2014) Immunosuppression in patients with chronic hepatitis B. Curr Hepatol Rep 13:235–244

    Article  PubMed  PubMed Central  Google Scholar 

  68. Yuen MF, Sablon E, Wong DK, Yuan HJ, Wong BC, Chan AO, Lai CL (2003) Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 37:593–597

    Article  PubMed  Google Scholar 

  69. Kunnathuparambil SG, Vinayakumar KR, Varma MR, Thomas R, Narayanan P, Sreesh S (2014) Bilirubin, aspartate aminotransferase and platelet count score: a novel score for differentiating patients with chronic hepatitis B with acute flare from acute hepatitis B. Ann Gastroenterol 27(1):60–64

    PubMed  PubMed Central  Google Scholar 

  70. Chu CM, Sheen IS, Yeh CT, Hsieh SY, Tsai SL, Liaw YF (1995) Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. Dig Dis Sci 40(10):2107–2112

    Article  PubMed  CAS  Google Scholar 

  71. Pan CJ, Wu HL, Kuo SF, Kao JH, Tseng TC, Liu CH, Chen PJ, Liu CJ, Chen DS (2012) Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B. Hepatol Int 6(3):591–597

    Article  PubMed  Google Scholar 

  72. Wu HL, Kao JH, Chen TC, Wu WH, Liu CH, Su TH, Yang HC, Chen DS, Chen PJ, Liu CJ (2014) Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. J Gastroenterol Hepatol 29(8):1629–1636

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Human Virology, Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil

    R. A. A. Pondé

  2. Central Goiana de Sorologia, Imuno-hematologia e Biologia Molecular, Goiânia, Goiás, Brazil

    R. A. A. Pondé

  3. SUVISA—Superintendência de Vigilância em Saúde, Secretaria Estadual de Saúde, Coordenação Estadual de Controle das Hepatites Virais (CECHV), Goiânia, Goiás, Brazil

    R. A. A. Pondé

  4. Rua 7A Edifício RIOL, Nº 158, 1º andar, sala 101, setor aeroporto, Goiânia, Goiás, 74-075-030, Brazil

    R. A. A. Pondé

Authors
  1. R. A. A. Pondé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. A. A. Pondé.

Ethics declarations

Conflict of interest

The author declares that there are no competing interests (financial or non-financial) related to the content of the specific article. The author further states that this paper comprises a review article and that, for its compilation, it did not require research involving human participants and/or animals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pondé, R.A.A. Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis. Eur J Clin Microbiol Infect Dis 35, 29–40 (2016). https://doi.org/10.1007/s10096-015-2522-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-015-2522-7

Keywords

Search

Navigation